ClinicalTrials.govpublic full text
Compliance to the Treatment With GRAZAX® Tablets in Patients With Seasonal Grass Pollen Rhinoconjunctivitis
allergic rhinitis, grass allergy, specific allergen immunotherapy, sublingual immunotherapy, allergen tablets, compliance, electronic compliance device, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 860806
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.